{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:12:16Z","timestamp":1792735936708,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.10.045","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T22:01:02Z","timestamp":1445810462000},"page":"1133-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger"],"prefix":"10.1016","volume":"34","author":[{"given":"Maite","family":"Irurzun-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozi A.","family":"Erondu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Djibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ronveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Le Gargasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Colombini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.045_bib0130","unstructured":"World Health Organization (WHO). Meningococcal meningitis. Fact sheet No. 141. Geneva: WHO. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/ [accessed 7.04.14]."},{"key":"10.1016\/j.vaccine.2015.10.045_bib0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0145","series-title":"Epidemic meningitis surveillance in the African meningitis belt: deciding on the most appropriate approach","author":"WHO","year":"2014"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0150","series-title":"Technical guidelines for integrated disease surveillance and response in the African region","author":"WHO","year":"2010"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-7-1","article-title":"Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali","volume":"7","author":"Somda","year":"2009","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0160","doi-asserted-by":"crossref","first-page":"C88","DOI":"10.1016\/j.vaccine.2013.05.036","article-title":"Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica","volume":"31S","author":"Toscanoa","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0165","series-title":"SurvCost 1.0: a manual to assist country and district public health officials in estimating the cost of the implementation of integrated disease surveillance and response systems","author":"Centre for Disease Control (CDC)","year":"2007"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0170","series-title":"Generic guide for case-based surveillance of bacterial meningitis in the WHO African region","author":"WHO-Regional Office for Africa (AFRO)","year":"2009"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0175","series-title":"Standard operating procedures for enhanced meningitis surveillance in Africa","author":"WHO Regional Office for Africa (AFRO)","year":"2009"},{"issue":"7 Suppl. 1","key":"10.1016\/j.vaccine.2015.10.045_bib0180","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/MLR.0b013e31819bc064","article-title":"Micro-costing quantity data collection methods","volume":"47","author":"Frick","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0185","series-title":"World development indicators","author":"World Bank","year":"2013"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0190","series-title":"SurvCost 1.0: a manual to assist country and district public Health officials in estimating the cost of the implementation of integrated disease surveillance and response systems","author":"Centre for Disease Control (CDC)","year":"2007"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2458-2-2","article-title":"Conceptual framework of public health surveillance and action and its application in health sector reform","volume":"2","author":"McNabb","year":"2002","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0200","doi-asserted-by":"crossref","first-page":"C88","DOI":"10.1016\/j.vaccine.2013.05.036","article-title":"Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica","volume":"31S","author":"Toscano","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/17441690903334943","article-title":"Implementing integrated disease surveillance and response: four African countries\u2019 experience, 1998\u20132005","volume":"5","author":"Nsubuga","year":"2010","journal-title":"Glob Public Health"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1403494808101179","article-title":"Communicable diseases surveillance lessons learned from developed and developing countries: literature review","volume":"37","author":"Sahal","year":"2009","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/heapol\/czt097","article-title":"Challenges with the implementation of an Integrated Disease Surveillance and Response (IDSR) system: systematic review of the lessons learned","author":"Phalkey","year":"2015","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0220","series-title":"Surveillance Microbiologique Des M\u00e9ningites Bact\u00e9riennes Aigues au Niger. Saison 2012 (Novembre 2011-Juin 2012)","author":"CERMES","year":"2012"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0225","series-title":"Plan pilote de mise en \u0153uvre de la surveillance cas par cas de m\u00e9ningite au Niger","author":"Minist\u00e8re de la Sant\u00e9 Publique Niger","year":"2013"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0230","series-title":"Plan d\u2019action annuel pour la mise en ceuvre de la surveillance cas par cas de la meningite bacterienne. Janvier \u00e0 d\u00e9cembre 2013","author":"Minist\u00e8re de la Sant\u00e9 Publique Chad","year":"2012"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3201\/eid2101.140256","article-title":"Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013","volume":"21","author":"Gamougam","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0240","series-title":"R\u00e9sultats d\u2019examens de LCR (bact\u00e9riologie et\/ou PCR)","author":"CERMES","year":"2013"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0245","series-title":"Stop Transmission of Polio (STOP) Tchad Team Final Report","author":"Minist\u00e8re de Sant\u00e9 Publique du Tchad","year":"2014"},{"key":"10.1016\/j.vaccine.2015.10.045_bib0250","series-title":"Annuaire des statistiques sanitaires de Niger","author":"R\u00e9publique du Niger","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T05:56:24Z","timestamp":1712382984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15014607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15014607"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}